Your browser doesn't support javascript.
loading
Liposomal Nanodrug Based on Norcantharidin Derivative for Increased in Vivo Activity.
Kuang, Hailong; Wang, Peipei; Wang, Yuhang; Li, Jinbo; Yu, Jiang; Jia, Lirui; Li, Shuo; Ma, Yan; Liu, Hongzhuo; He, Zhonggui; Wang, Yongjun.
Afiliação
  • Kuang H; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.
  • Wang P; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.
  • Wang Y; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.
  • Li J; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.
  • Yu J; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.
  • Jia L; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.
  • Li S; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.
  • Ma Y; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Liu H; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.
  • He Z; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China. hezhonggui@vip.163.com.
  • Wang Y; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China. wangyongjun@syphu.edu.cn.
AAPS PharmSciTech ; 24(5): 118, 2023 May 10.
Article em En | MEDLINE | ID: mdl-37165275

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Antineoplásicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Antineoplásicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China